FDA Approves Avastin for Most Common Kidney Cancer

The drug Avastin has been approved in the United States for treating patients with metastatic renal cell carcinoma, the most common form of kidney cancer.

The Food and Drug Administration approved Avastin to be used in combination with the drug interferon-alpha, Agence France Presse reported.

A study found that patients treated with a combination of the drugs lived nearly twice as long without disease progression compared to patients treated with only interferon-alpha.

Since the end of 2007, Avastin has been available in Europe as a first-line treatment for advanced kidney cancer, AFP reported. Last week, European officials approved the drug for treatment of breast cancer.

More on This

• Red meat lovers have more kidney cancer
• Pfizer cancer drug effect may be limited-FDA staff
• More painkiller use linked to kidney cancer
• Arsenic linked to kidney cancer

Tags

• Kidney Cancer

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Do you really want to post anonymously?

Are You a Member? Log InConnect your comment to your member profile. It only takes a second! Not a Member? Join Now!You'lll be automatically notified when someone else comments on your post.

Tell us what you think Write your comment here *

Leave this field blank

Receive email notifications of new comments Email Addresss

Sign me up for EmpowHER's FREE Newsletter!

Type in the characters above *

By hitting submit, you agree to EmpowHER's terms of service and privacy policy